Evaluation of drug permeability across Ex vivo nasal mucosa: A simulation-based approach to minimize thickness-related variability
Journal of Drug Delivery Science and Technology · 2025-06 · 108 · 106959
DOI: 10.1016/j.jddst.2025.106959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery Science and Technology, 2025-06. Verfasst von Shengnan Zhao und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Canadian Stroke Consortium.
Abstract (Originalsprache)
Ex vivo nasal mucosa is commonly used for the study on drug permeability for nasal drug delivery. Thickness variations in porcine nasal mucosa (0.26–1.47 mm) were found to significantly impact permeation curve results in Franz diffusion cell experiments, introducing variability and complicating data interpretation. To mitigate these effects, a numerical simulation method was developed using COMSOL Multiphysics® to normalize permeation curve to a standardized mucosal thickness. Using this method, the permeability of five compounds with diverse solubility and lipophilicity profiles was evaluated. Melatonin, triamcinolone acetonide, and mitragynine exhibited high permeability, while cannflavin A and cannflavin B showed negligible permeability. The apparent permeability coefficients (Papp) of mitragynine, melatonin, and triamcinolone acetonide were initially obscured by differences in mucosal thickness, masking their statistical differences. However, after normalization, statistically significant differences became evident. These findings highlight the critical role of mucosal thickness correction in ex vivo permeability studies to ensure accurate and comparable data across different experimental setups and drug candidates, supporting the development of reliable nasal drug delivery systems. Furthermore, this method can be extended to permeability studies involving other species or even other types of tissues, broadening its applicability and potential in drug delivery research.
Förderung
- China Scholarship Council
- Canadian Stroke Consortium
Zitieren
APA
Zhao, S., Zhao, Y., Zuo, J., Le, T. S., Kerdsiri, J., Waranuch, N., Davies, N. M., & Löbenberg, R. (2025). Evaluation of drug permeability across Ex vivo nasal mucosa: A simulation-based approach to minimize thickness-related variability. Journal of Drug Delivery Science and Technology, 108, 106959. https://doi.org/10.1016/j.jddst.2025.106959
Vancouver
Zhao S, Zhao Y, Zuo J, Le TS, Kerdsiri J, Waranuch N, et al. Evaluation of drug permeability across Ex vivo nasal mucosa: A simulation-based approach to minimize thickness-related variability. Journal of Drug Delivery Science and Technology. 2025;108:106959. doi:10.1016/j.jddst.2025.106959
BibTeX
@article{Zhao2025,
author = {Zhao, Shengnan and Zhao, Yuanheng and Zuo, Jieyu and Le, Tyson S. and Kerdsiri, Jeerakit and Waranuch, Neti and Davies, Neal M. and Löbenberg, Raimar},
title = {Evaluation of drug permeability across Ex vivo nasal mucosa: A simulation-based approach to minimize thickness-related variability},
journal = {Journal of Drug Delivery Science and Technology},
year = {2025},
volume = {108},
pages = {106959},
doi = {10.1016/j.jddst.2025.106959}
}
EUVIMED